Document Classification

Section Type: RESULTS

Text: Among the primary end points, the incidence of deaths from CHD was 3. 79 % in the treatment group and 5. 49 % in the control group, with a reduction of relative risk by 31. 0 % in treatment group (P < 0. 0048) ; (2) The incidence of nonfatal myocardial infarction reduced by 60. 8 % in treatment group compared to control group (1. 93 % vs 4. 92 %, P < 0. 0000) ; (3) The incidence of the secondary end-points (stroke, tumor, PCI/CABG) also decreased by 31. 1 % in treatment group compared to control group (6. 92 % vs 10. 04 % P < 0. 0004).